Ceramic Industry
  Home
  Subscribe
  Digital Edition Subscribe
  CyberNews Subscribe
  Editor's Blog
  PPP HotSpot
  Subscription Customer Service
  Online
  Classified Ads
  Services Marketplace
  Buyers' Connections
  Ad Index
  Calendar
  Today's Headlines
  Cover Story
  Features
  Columns
  Products
  Online Extras
  Resources
  Archives
  Digital Edition Archives
  Career Center
  CyberNews Archives
  Advanced Ceramics & Glasses Digest eNews Archives
  Directories
  Videos
  Podcasts
  Reference
  Market Research
  Web Seminars
  CI Info
  About CI
  Contact Us
  Media Kit
  Reprints
Search in: EditorialProductsCompanies
Corning Acquires Axygen BioScience (posted 9/17/09)

September 17, 2009

ARTICLE TOOLS
EmailEmailPrintPrintReprintsReprintsshareShare



Corning Inc. recently announced that it has acquired all of the shares of Axygen BioScience, Inc. and its subsidiaries from American Capital Ltd. for approximately $400 million in cash. Headquartered in Union City, Calif., Axygen is a leading manufacturer and distributor of high-quality life sciences plastic consumable labware, liquid handling products, and bench-top laboratory equipment with operations in the U.S., France, Poland, and China. Axygen will be integrated into Corning’s Life Sciences segment.

The acquisition supports Corning’s ongoing commitment to supply its customers with a comprehensive and innovative line of laboratory research products. Axygen’s product portfolio of high-quality plastic consumables (including pipettes, pipette tips and high-throughput screening products) and lab equipment (including centrifuges, pipette controllers and incubators) expands on and complements the general labware, cell culture and HTS/assay products offered by Corning. In addition, the acquisition enhances Corning’s presence in Asia through Axygen’s two manufacturing locations and increases access to customers in the Asia region.

“Axygen’s product portfolio and established distribution network will significantly strengthen Corning’s life sciences platform and are critical components to our long-term growth strategy for this business,” said Peter F. Volanakis, Corning’s president and chief operating officer. “We believe this highly strategic acquisition offers synergies that will allow us to grow our life sciences business to more than $500 million in revenue by 2011.”

“We are looking forward to working with Axygen’s talented management team, whose leadership and vision have resulted in a set of brands recognized for quality and innovation by customers around the world,” said Mark A. Beck, senior vice president of Corning Life Sciences.

Hemant Gupta, Axygen’s founder, will remain with the business, serving as president and CEO, as will other key personnel of Axygen. “We are very excited to be joining the Corning organization,” said Gupta. “Corning is a world leader in bringing innovative scientific labware products to market, and we are looking forward to making major contributions to the continued success of this well-respected organization.”

Visit www.corning.com or www.axygen.com for more information.


Links

|PrintEmail

Did you enjoy this article? Click here to subscribe to the magazine.






BNP Media
© 2010 BNP Media. All rights reserved. The publisher is not responsible for product claims and representations. Any views or opinions expressed are those of the author and do not represent those of Ceramic Industry, its staff, Editorial Advisory Board or BNP Media. | Privacy Policy